http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019074498-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d16bf94e8c835c01ce8777b78c6ff84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a50db55461e15c1b8fe037489533885
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2017-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed8ed3852ec0ffa910fe744bf5f921c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb654a7aa48f6a43f605bf87104de490
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70df272ac48d673e5b535f6a6d71e311
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_448100f6f25274501453058b1571893b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f59796fd8b069a6acde761d8342ce19a
publicationDate 2019-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019074498-A1
titleOfInvention COMPOSITIONS AND METHODS FOR INCREASING THE HALF-LIFE OF A PROTEIN IN A SERUM
abstract The invention relates to novel antibodies, such as single-domain antibodies (sdAbs) or antigen-binding fragments thereof that specifically bind to a transferrin. The invention also provides compositions, methods and systems for increasing the half-life of a target protein in a serum using an antibody or fragment thereof directed against a transferrin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023142109-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021198396-A1
priorityDate 2017-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016200830-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015121092-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9193780-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010172894-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011051327-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10444661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274

Total number of triples: 55.